Home » Topics » BioWorld Science

BioWorld Science
RSS

Pierre Fabre reveals cancer treatment agents

June 21, 1996

Bristol-Myers Squibb isolates and synthesizes hayumicin antitumor antibiotics

June 21, 1996

Anergen issued European patent on AnergiX compounds

June 21, 1996

RPR granted rights to Gliadel

June 21, 1996

Antibody production-enhancing peptides described

June 21, 1996

Cyclolignan derivatives disclosed

June 21, 1996

Toyama's T-614 enters phase I in U.K.

June 21, 1996

Albenza receives U.S. marketing approval

June 21, 1996

Y-ART-3: Promising HIV treatment candidate

June 21, 1996

HIV protease inhibitors from Warner-Lambert

June 21, 1996

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...